Systematic review and evidence gap mapping of biomarkers associated with neurological manifestations in patients with COVID-19 K. Z. A. DominguesA. F. CobreR. Pontarolo Review 28 November 2023 Pages: 1 - 23
SARS-CoV-2 vaccination and multiple sclerosis: a large multicentric study on relapse risk after the third booster dose Massimiliano Di FilippoDiana Ferrarothe RIREMS (Rising Researchers in MS) group Original Communication Open access 03 November 2023 Pages: 24 - 31
The impact of COVID-19 infection, the pandemic and its associated control measures on patients with Pompe disease Maudy T. M. TheunissenRenee M. van den ElsenNadine A. M. E. van der Beek Original Communication Open access 20 November 2023 Pages: 32 - 45
Persistent cognitive slowing in post-COVID patients: longitudinal study over 6 months Eva Maria MartinAnnie SrowigKathrin Finke Original Communication Open access 07 November 2023 Pages: 46 - 58
Cerebrospinal fluid findings in patients with neurological manifestations in post-COVID-19 syndrome Fabian BoeslYasemin GoereciChristiana Franke Original Communication Open access 24 November 2023 Pages: 59 - 70
Susac syndrome in a patient with migraine shortly after COVID-19 booster vaccination: more than a temporal relation? Stergios TsitosAdrian DanekAndreas Straube Letter to the Editors Open access 09 November 2023 Pages: 71 - 74
Subacute transverse myelitis of possible vasculitic origin after SARS-CoV2 and Varicella-Zoster virus infections: a case report Francesco FavruzzoAnna PalmieriDomenico Marco Bonifati Letter to the Editors 09 December 2023 Pages: 75 - 78
Long-term neurological symptoms after acute COVID-19 illness requiring hospitalization in adult patients: insights from the ISARIC-COVID-19 follow-up study Denise BattagliniNicole M. WhiteISARIC Clinical Characterization Group Letter to the Editors Open access 06 December 2023 Pages: 79 - 86
Understanding the genetic mechanisms and cognitive impairments in Down syndrome: towards a holistic approach Yara AbukhaledKenana HatabHamdan Hamdan Review Open access 10 August 2023 Pages: 87 - 104
Multiple sclerosis: time for early treatment with high-efficacy drugs Krzysztof SelmajBruce A. C. CreeHans-Peter Hartung Review Open access 18 October 2023 Pages: 105 - 115
The elusive nature of the oligoclonal bands in multiple sclerosis Peter G. E. KennedyWoro GeorgeXiaoli Yu Review 09 November 2023 Pages: 116 - 124
Real-life evaluation of the 2017 McDonald criteria for relapsing–remitting multiple sclerosis after a clinically isolated syndrome confirms a gain in time-to-diagnosis Mickaël FerrandJonathan EpsteinGuillaume Mathey Original Communication 31 August 2023 Pages: 125 - 133
Hepatitis B reactivation is a rare event among patients with resolved infection undergoing anti-CD20 antibodies in monotherapy without antiviral prophylaxis: results from the HEBEM study Blanca MarzoAngela Vidal-JordanaMar Riveiro-Barciela Original Communication Open access 11 September 2023 Pages: 134 - 140
Update on the diagnosis and treatment of neuromyelitis optica spectrum disorders (NMOSD) – revised recommendations of the Neuromyelitis Optica Study Group (NEMOS). Part II: Attack therapy and long-term management Tania KümpfelKatrin GiglhuberThe Neuromyelitis Optica Study Group (NEMOS) Review Open access 07 September 2023 Pages: 141 - 176
IQ changes after pediatric epilepsy surgery: a systematic review and meta-analysis Tristan SchmidlechnerMalin ZaddachIngo Borggraefe Review Open access 28 September 2023 Pages: 177 - 187
Informed consent practices for acute stroke therapy: principles, challenges and emerging opportunities Amir MbondeMichael J. YoungRobert W. Regenhardt Review 10 October 2023 Pages: 188 - 197
High intake of ultra-processed food is associated with dementia in adults: a systematic review and meta-analysis of observational studies Alex E. HenneyConor S. GillespieDaniel J. Cuthbertson Review Open access 13 October 2023 Pages: 198 - 210
eHealth tools to assess the neurological function for research, in absence of the neurologist – a systematic review, part I (software) Vasco Ribeiro FerreiraEsther MettingValentina Gallo Review Open access 17 October 2023 Pages: 211 - 230
Concurrence of seizures and peri-ictal delirium in the critically ill - its frequency, associated characteristics, and outcomes Anja I. FreiAnna S. WagnerRaoul Sutter Original Communication Open access 07 September 2023 Pages: 231 - 240
Modifiable risk factors for multiple sclerosis have consistent directions of effect across diverse ethnic backgrounds: a nested case–control study in an English population-based cohort Benjamin M. JacobsPooja TankRuth Dobson Original Communication Open access 07 September 2023 Pages: 241 - 253
Efgartigimod beyond myasthenia gravis: the role of FcRn-targeting therapies in stiff-person syndrome Vincenzo Di StefanoPaolo AlongeFilippo Brighina Original Communication Open access 08 September 2023 Pages: 254 - 262
Pooled analysis of patients with inherited prion disease caused by two- to twelve-octapeptide repeat insertions in the prion protein gene (PRNP) Astrid Van den BroeckeAlexander DecruyenaereDimitri Hemelsoet Original Communication 09 September 2023 Pages: 263 - 273
Insomnia and sleep-disordered breathing in FKRP-related limb-girdle muscular dystrophy R9. The Norwegian LGMDR9 cohort study (2020) Synnøve JensenKarin AbelerKjell Arne Arntzen Original Communication Open access 11 September 2023 Pages: 274 - 288
The relationship between disease-specific psychosocial stressors and depressive symptoms in Huntington’s disease Hiba BilalIan H. HardingJulie C. Stout Original Communication Open access 11 September 2023 Pages: 289 - 299
MRI abnormalities in Creutzfeldt–Jakob disease and other rapidly progressive dementia Renzo ManaraFederica FragiacomoAnnachiara Cagnin Original Communication Open access 12 September 2023 Pages: 300 - 309
Characterizing cognitive function in patients with autoimmune encephalitis: an Australian prospective study Sarah P. GriffithRobb WesselinghAustralian Autoimmune Encephalitis Consortium Original Communication Open access 14 September 2023 Pages: 310 - 324
Impairment of oculomotor functions in patients with early to advanced amyotrophic lateral sclerosis Elisa AustSven-Thomas GraupnerAndreas Hermann Original Communication Open access 15 September 2023 Pages: 325 - 339
Intravenous or subcutaneous natalizumab in patients with relapsing–remitting multiple sclerosis: investigation on efficiency and savings—the EASIER study Massimo FilippiLuigi Grimaldithe EASIER Study Working Group Original Communication Open access 16 September 2023 Pages: 340 - 354
Multimodal MRI study on the relation between WM integrity and connected GM atrophy and its effect on disability in early multiple sclerosis Merlin M. WeedaD. R. van NederpeltP. J. W. Pouwels Original Communication Open access 17 September 2023 Pages: 355 - 373
Long-term outcome of natalizumab-associated progressive multifocal leukoencephalopathy in Austria: a nationwide retrospective study Tobias MoserGeorg ZimmermannJohann Sellner Original Communication Open access 20 September 2023 Pages: 374 - 385
Neurological manifestation of HEV infection: still a rare disease entity? Maximilian WiesenfarthThomas StammingerAlbert C. Ludolph Original Communication Open access 22 September 2023 Pages: 386 - 394
International survey on the implementation of the European and American guidelines on disorders of consciousness Michele FariscoRita FormisanoIBIA Special Interest Group on DoCs Original Communication Open access 23 September 2023 Pages: 395 - 407
Correction to: International survey on the implementation of the European and American guidelines on disorders of consciousness Michele FariscoRita FormisanoIBIA Special Interest Group on DoCs Correction Open access 22 November 2023 Pages: 408 - 409
Face to Face: deciphering facial involvement in inclusion body myositis Etienne FortanierEmilien DelmontEmmanuelle Salort-Campana Original Communication 23 September 2023 Pages: 410 - 418
Dystonia and Parkinsonism in COA7-related disorders: expanding the phenotypic spectrum Yujiro HiguchiMasahiro AndoHiroshi Takashima Original Communication Open access 26 September 2023 Pages: 419 - 430
Language deficits in primary lateral sclerosis: cortical atrophy, white matter degeneration and functional disconnection between cerebral regions Ee Ling TanMarlene TahedlPeter Bede Original Communication 27 September 2023 Pages: 431 - 445
Pathological findings in autoimmune encephalitis autopsy specimens from cases of suspected prion disease Christina KernerKeisi KotobelliHesham Abboud Original Communication 27 September 2023 Pages: 446 - 456
Correlation of glymphatic system abnormalities with Parkinson’s disease progression: a clinical study based on non-invasive fMRI Jing-Cai MengMing-Qiang ShenQian Gui Original Communication 27 September 2023 Pages: 457 - 471
Examining the environmental risk factors of progressive-onset and relapsing-onset multiple sclerosis: recruitment challenges, potential bias, and statistical strategies Ying LiAlice SaulIngrid van der Mei Original Communication Open access 28 September 2023 Pages: 472 - 485
Alemtuzumab induces severe orbitopathy in relapsing–remitting multiple sclerosis Pablo Rodríguez de Vera GómezMariola Méndez MurosTomás Martín Hernández Original Communication 29 September 2023 Pages: 486 - 496
Phenotype-driven reanalysis reveals five novel pathogenic variants in 40 exome-negative families with Charcot–Marie–Tooth Disease Zhiqiang LinLei LiuRuxu Zhang Original Communication 30 September 2023 Pages: 497 - 503
Neuroimaging determinants of cognitive impairment in the memory clinic: how important is the vascular burden? Daniela AndriutaEmmanuel WienerOlivier Godefroy Original Communication 01 October 2023 Pages: 504 - 518
Prevalence, demographic and spatial distribution of treated epilepsy in France in 2020: a study based on the French national health data system Joël CosteLaurence Mandereau-BrunoViviane Bouilleret Original Communication Open access 03 October 2023 Pages: 519 - 525
Clinical and genetic analyses of a Swedish patient series diagnosed with ataxia Sorina GorcencoEfthymia KafantariAndreas Puschmann Original Communication Open access 03 October 2023 Pages: 526 - 542
Factors impacting trial participation in people with motor neuron disease Emily BeswickMicheala JohnsonSuvankar Pal Original Communication Open access 03 October 2023 Pages: 543 - 552
A retrospective study of autoimmune cerebellar ataxia over a 20-year period in a single institution Akihiko KudoHiroaki YaguchiIchiro Yabe Short Commentary 23 August 2023 Pages: 553 - 563
Weaning and extubation failure in myasthenic crisis: a multicenter analysis Bernhard NeumannKlemens AngstwurmOn behalf of the Initiative of German NeuroIntensive Trial Engagement (IGNITE) Short Commentary 03 November 2023 Pages: 564 - 574
Liquid biopsy of cerebrospinal fluid enabling the detection and therapeutic targeting of the BRAFV600E mutation in a patient with overlapping Erdheim-Chester/Rosai-Dorfman disease Valentina PieriGiulia BerzeroMassimo Filippi Letter to the Editors 19 September 2023 Pages: 575 - 579
Conjugate torsional pendular nystagmus and palatal tremor after unilateral internuclear ophthalmoplegia Hyung LeeJi-Soo KimHyun Ah Kim Letter to the Editors 26 September 2023 Pages: 580 - 583
Refractory generalized myasthenia gravis treated successfully with telitacicept: two cases report Zhouao ZhangZhouyi WangYong Zhang Letter to the Editors 07 October 2023 Pages: 584 - 588
